277 related articles for article (PubMed ID: 31115967)
1. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
[TBL] [Abstract][Full Text] [Related]
2. [Dermatofibrosarcoma protuberans].
Ugurel S
Hautarzt; 2008 Nov; 59(11):933-9; quiz 940. PubMed ID: 18936902
[TBL] [Abstract][Full Text] [Related]
3. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
4. Current treatment options for dermatofibrosarcoma protuberans.
Rutkowski P; Debiec-Rychter M
Expert Rev Anticancer Ther; 2015; 15(8):901-9. PubMed ID: 26027711
[TBL] [Abstract][Full Text] [Related]
5. Current treatment options in dermatofibrosarcoma protuberans.
Lemm D; Mügge LO; Mentzel T; Höffken K
J Cancer Res Clin Oncol; 2009 May; 135(5):653-65. PubMed ID: 19205737
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
7. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
10. [New molecular approaches in dermatofibrosarcoma protuberans].
Kaya G
Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
[TBL] [Abstract][Full Text] [Related]
11. Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.
Iwasaki T; Yamamoto H; Oda Y
Curr Treat Options Oncol; 2019 Mar; 20(4):29. PubMed ID: 30874910
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.
Saiag P; Grob JJ; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Stratigos A; Middelton M; Basholt L; Testori A; Garbe C
Eur J Cancer; 2015 Nov; 51(17):2604-8. PubMed ID: 26189684
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
[TBL] [Abstract][Full Text] [Related]
15. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma Protuberans: The Current State of Multidisciplinary Management.
Ramirez-Fort MK; Meier-Schiesser B; Niaz MJ; Niaz MO; Feily A; Fort M; Lange CS; Caba D
Skinmed; 2020; 18(5):288-293. PubMed ID: 33160438
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma Protuberans: What Is This?
Vitiello GA; Lee AY; Berman RS
Surg Clin North Am; 2022 Aug; 102(4):657-665. PubMed ID: 35952694
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
